[Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026!
Exhibitor: UVAT TECHNOLOGY CO., LTD.
Date: 2026-07-09
Booth No.: N602
Driving Next-Generation Biomedical Devices: Advanced Plasma Surface Modification & Conductive Metal Thin-Film Applications
The diagnostic precision of next-generation biochips and high-end medical devices hinges on the microscopic characteristics of their material surfaces. Ultra-Vacuum Advanced Technology (UVAT) is proud to announce our participation in BIO Asia-Taiwan 2026 this July!
Leveraging our deep-rooted expertise in semiconductor and precision vacuum processing, UVAT will present core solutions in "Plasma Surface Activation & Modification" and "Conductive Metal Thin-Film Applications." We aim to empower global biomedical partners in overcoming manufacturing bottlenecks and accelerating commercialization.
-
Exhibition Date: July 2026
-
Venue: Taipei Nangang Exhibition Center, Taipei, Taiwan
💡 Two Core Technology Solutions on Display
In the development of In Vitro Diagnostics (IVD), microfluidic chips, and wearable medical sensors, developers frequently face challenges such as high substrate hydrophobicity, fluid resistance, and poor biomolecule adhesion. UVAT offers revolutionary, dry vacuum solutions tailored to these pain points:
1. Plasma Surface Activation & Modification —— Achieving Superior Hydrophilicity & Biofunctionalization
Utilizing a purely dry, low-temperature plasma process, this technology is uniquely designed for heat-sensitive medical polymers (e.g., PET, COP, COC) and micro-wires:
-
Microfluidic Optimization: Rapidly enhances channel surface wettability to ensure smooth fluid flow, eliminating diagnostic errors caused by bubble entrapment.
-
Enhanced Biomolecule Immobilization: Boosts the binding efficiency of antibodies, proteins, or DNA probes through precise surface functionalization.
-
Safe & Non-Destructive: Operates entirely without chemical residues or cytotoxicity risks, meeting stringent medical regulatory standards (e.g., ISO 10993).
2. Conductive Metal Thin-Film Applications —— Building the Sensing Core for High-Precision Devices
Utilizing advanced vacuum sputtering technology, UVAT deposits uniform, nano-scale metal layers onto diverse biomedical substrates:
-
High-Purity Precious Metal Sputtering: Supports Gold (Au), Platinum (Pt), and other precious metal deposition to construct dense Biosensing Microelectrode Arrays (MEAs) for IVD and POCT diagnostic chips.
-
Superior Interfacial Adhesion: Proprietary vacuum processes significantly strengthen adhesion between metal films and flexible substrates, withstanding prolonged chemical immersion and the repeated bending required by wearable devices.
🤝 From Lab-Scale Prototyping to Industrial Mass Production
UVAT is dedicated to enhancing surface hydrophilicity, improving biomolecule immobilization, and delivering highly stable coatings alongside advanced surface activation and modification. Beyond offering lab-scale testing and prototyping services during early R&D, we provide full-scale automated mass production equipment (such as Roll-to-Roll sputtering/plasma systems)—making us your premier strategic partner for bridging the gap from laboratory research to commercial-scale manufacturing.
We cordially invite R&D teams, medical device manufacturers, and IVD experts to visit the UVAT booth to discuss your surface modification and coating needs with our technical specialists!
More Exhibitor's Press Release
- Wallonia exhibits at BIO Asia-Taiwan 2026 for the 3rd consecutive year: showcasing biotech strengths WALLONIA EXPORT-INVESTMENT AGENCY,BELGIUM / 2026-07-21
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08
- Lonza Acquires Rights to Nona Biosciences’ TfR1 Blood-Brain Barrier Technology and Expands Strategic LONZA / 2026-07-08